Alan Milburn Criticizes Youth Benefit Spending Outpacing Job Creation Calls for Welfare Reform Space Stocks Surge After SpaceX Starship Incident Rocket Lab AST SpaceMobile Lead Gains Egypt QatarEnergy and ExxonMobil Partner to Ship Cypriot Gas to Europe via Egyptian LNG Facilities Gold Price Outlook Could 6000 Be on the Horizon for 2026 Bureau of Prisons Embraces AI Technology Large Contract Signals Shift in Government Operations UK Bank Holiday Travel Delays and Record Heat Signal Busy Summer for Travel Sector MLYS Q1 2026 Earnings EPS In Line with Estimates No Revenue Yet Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises BLNE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines 52 ZS Q1 2026 Earnings EPS Surprises to the Upside Amidst Growth Focus PLAG Q3 2023 Earnings Net Loss per Share Reported Amid Limited Disclosure PETS Q1 2026 Earnings Significant Earnings Miss Despite Positive Stock Reaction Incannex Healthcare IXHL Slides 16 as Stock Nears Support at 34 LiveOne Inc LVO Surges 743 Testing Resistance After Strong Uptick Aviat Networks AVNW Posts Modest Gain Approaches Resistance Zone Fathom Holdings FTHM Slides 7 as Stock Tests Key Support Near 056 Associated BancCorp ASB Faces Headwinds as Shares Dip Nearly 1 European Media Magnate Vincent Bollors Expanding Influence Sparks Debate on Democratic Safeguards AWK Q1 2026 Earnings EPS Falls Short of Estimates as Revenue Data Remains Unavailable Satellos Bioscience MSLE Slides 55 as Biotech Sector Headwinds Weigh on Sentiment Spencer Pratts Online Campaign Strategy May Reshape Political Engagement and Social Media Monetization Europes Digital Sovereignty at Risk Telecom Executive Warns of US Dominance in Satellites and AI Spotify Surges on AI Music Deal and LongTerm Growth Targets SpaceX Starship Launch Could Pave Way for Highly Anticipated IPO Goldman Sachs Reportedly Poised to Lead SpaceX IPO in What Would Be Landmark Deal MIDD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development